Shanghai Desano Chemical Pharmaceutical is an API manufacturer based in China. It holds 32 active US drug master files and 10 valid CEPs. Its GMP standing is certified by MHRA (UK) and US FDA. Its most recent recorded inspection, by US FDA, closed on 17 November 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Laogang Town, China | Not on file |
| SHANGHAI, China | Not on file |
| China, China | 3006895951 |
| Molecule | Regulators | Docs |
|---|---|---|
| Lamivudine | EDQM, US FDA | 3 |
| Ritonavir | EDQM, US FDA | 3 |
| Atazanavir | EDQM, US FDA | 2 |
| Lopinavir | US FDA | 2 |
| Nevirapine | EDQM, US FDA | 2 |
| Praziquantel | EDQM, US FDA | 2 |
| Zidovudine | EDQM, US FDA | 2 |
| Abacavir | EDQM | 1 |
| Atovaquone | US FDA | 1 |
| Cabotegravir | US FDA | 1 |
| Canagliflozin | US FDA | 1 |
| Dolutegravir | US FDA | 1 |
| Dotinurad | US FDA | 1 |
| Edoxaban | US FDA | 1 |
| Efavirenz | US FDA | 1 |
| Elagolix | US FDA | 1 |
| Eltrombopag | US FDA | 1 |
| Elvitegravir | US FDA | 1 |
| Emtricitabine | US FDA | 1 |
| Finerenone | US FDA | 1 |
| Isavuconazonium | US FDA | 1 |
| Lasmiditan | US FDA | 1 |
| Letermovir | US FDA | 1 |
| Lumefantrine | US FDA | 1 |
| Omadacycline | US FDA | 1 |
| Oseltamivir | US FDA | 1 |
| Raltegravir | EDQM | 1 |
| Rilpivirine | US FDA | 1 |
| Rosuvastatin | US FDA | 1 |
| Tedizolid | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| BOMRA (BW) | 1 | None |
| MHRA (UK) | None | 3 |
| US FDA | None | 1 |
Choose your molecules and target markets. Shanghai Desano Chemical Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free